{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:51:18Z","timestamp":1790653878137,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA039143"],"award-info":[{"award-number":["DA039143"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000074","name":"U.S. Department of Justice","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00213-022-06205-6","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T16:02:45Z","timestamp":1659801765000},"page":"3237-3248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice"],"prefix":"10.1007","volume":"239","author":[{"given":"Catheryn D.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9964-1593","authenticated-orcid":false,"given":"William E.","family":"Fantegrossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"issue":"4","key":"6205_CR1","doi-asserted-by":"publisher","first-page":"850.e5","DOI":"10.1016\/j.ajem.2019.11.014","volume":"38","author":"L Andreias","year":"2020","unstructured":"Andreias L, Roffe E, Eng A et al (2020) Synthetic cannabinoid receptor agonists-induced recurrent seizure in elderly patient. Am J Emerg Med 38(4):850.e5-850.e6","journal-title":"Am J Emerg Med"},{"issue":"2","key":"6205_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jelekin.2009.01.008","volume":"20","author":"TI Arabadzhiev","year":"2010","unstructured":"Arabadzhiev TI, Dimitrov VG, Dimitrova NA et al (2010) Interpretation of EMG integral or RMS and estimates of \u201cneuromuscular efficiency\u201d can be misleading in fatiguing contraction. J Electromyogr Kinesiol 20(2):223\u2013232","journal-title":"J Electromyogr Kinesiol"},{"issue":"2","key":"6205_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0376-8716(99)00152-0","volume":"60","author":"MM Aung","year":"2000","unstructured":"Aung MM, Griffin G, Huffman JW et al (2000) Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB (1) and CB (2) receptor binding. Drug Alcohol Depend 60(2):133\u2013140","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"6205_CR4","doi-asserted-by":"publisher","first-page":"a022863","DOI":"10.1101\/cshperspect.a022863","volume":"5","author":"M Barker-Haliski","year":"2015","unstructured":"Barker-Haliski M, White HS (2015) Glutamatergic mechanisms associated with seizures and epilepsy. Cold Spring Harb Perspect Med 5(8):a022863","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"9","key":"6205_CR5","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1111\/j.1528-1167.2009.02203.x","volume":"50","author":"HM Braakman","year":"2009","unstructured":"Braakman HM, van Oostenbrugge RJ, van Kranen-Mastenbroek VH et al (2009) Rimonabant induces partial seizures in a patient with a history of generalized epilepsy. Epilepsia 50(9):2171\u20132172","journal-title":"Epilepsia"},{"issue":"1","key":"6205_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1089\/can.2019.0003","volume":"5","author":"CS Breivogel","year":"2020","unstructured":"Breivogel CS, Wells JR, Jonas A et al (2020) Comparison of the neurotoxic and seizure-inducing effects of synthetic and endogenous cannabinoids with \u22069-tetrahydrocannabinol. Cannabis Cannabinoid Res 5(1):32\u201341","journal-title":"Cannabis Cannabinoid Res"},{"issue":"7","key":"6205_CR7","doi-asserted-by":"publisher","first-page":"e21917","DOI":"10.1371\/journal.pone.0021917","volume":"6","author":"LK Brents","year":"2011","unstructured":"Brents LK, Reichard EE, Zimmerman SM et al (2011) Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS ONE 6(7):e21917","journal-title":"PLoS ONE"},{"issue":"4","key":"6205_CR8","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1111\/j.1471-4159.1991.tb08313.x","volume":"57","author":"KJ Buck","year":"1991","unstructured":"Buck KJ, Hahner L, Sikela J et al (1991) Chronic ethanol treatment alters brain levels of gamma-aminobutyric acidA receptor subunit mRNAs: relationship to genetic differences in ethanol withdrawal seizure severity. J Neurochem 57(4):1452\u20131455","journal-title":"J Neurochem"},{"issue":"21-22","key":"6205_CR9","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1007\/s00213-016-4402-y","volume":"233","author":"I Canazza","year":"2016","unstructured":"Canazza I, Ossato A, Trapella C et al (2016) Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on \u201ctetrad\u201d, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies. Psychopharmacology (Berl) 233(21\u201322):3685\u20133709","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"6205_CR10","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1002\/hup.2601","volume":"32","author":"I Canazza","year":"2017","unstructured":"Canazza I, Ossato A, Vincenzi F et al (2017) Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies. Hum Psychopharmacol. 32(3):2601","journal-title":"Hum Psychopharmacol."},{"issue":"5","key":"6205_CR11","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1373\/clinchem.2016.267575","volume":"63","author":"J Carlier","year":"2017","unstructured":"Carlier J, Diao X, Scheidweiler KB et al (2017) Distinguishing intake of new synthetic cannabinoids ADB-PINACA and 5F-ADB-PINACA with human hepatocyte metabolites and high-resolution mass spectrometry. Clin Chem 63(5):1008\u20131021","journal-title":"Clin Chem"},{"issue":"1","key":"6205_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0014-2999(78)90374-6","volume":"47","author":"SA Castellani","year":"1978","unstructured":"Castellani SA, Ellinwood EH, Kilbey MM (1978) Tolerance to cocaine-induced convulsions in the cat. Eur J Pharmacol 47(1):57\u201361","journal-title":"Eur J Pharmacol"},{"key":"6205_CR13","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41598-020-57733-0","volume":"10","author":"MA Cozart","year":"2020","unstructured":"Cozart MA, Phelan KD, Wu H et al (2020) Vascular smooth muscle TRPC3 channels facilitate the inverse hemodynamic response during status epilepticus. Sci Rep 10:812","journal-title":"Sci Rep"},{"key":"6205_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1124\/jpet.111.188540","volume":"340","author":"RM Craft","year":"2012","unstructured":"Craft RM, Wakley AA, Tsutsui KT, Laggart JD (2012) Sex differences in CB1 vs. CB2 receptor-selective antagonism of antinociception produced by delta-9-THC and CP55,490 in the rat. J Pharmacol Exp Ther 340:787\u2013800","journal-title":"J Pharmacol Exp Ther"},{"key":"6205_CR15","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.pain.2013.05.017","volume":"154","author":"RM Craft","year":"2013","unstructured":"Craft RM, Kandasamy R, Davis SM (2013) Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of \u0394(9)-tetrahydrocannabinol in the rat. Pain 154:1709\u20131717","journal-title":"Pain"},{"issue":"1","key":"6205_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1042\/BJ20100751","volume":"433","author":"A Crespillo","year":"2011","unstructured":"Crespillo A, Su\u00e1rez J, Berm\u00fadez-Silva FJ et al (2011) Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade. Biochem J 433(1):175\u2013185","journal-title":"Biochem J"},{"issue":"4","key":"6205_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/1941874411417977","volume":"1","author":"A de Havenon","year":"2011","unstructured":"de Havenon A, Chin B, Thomas KC et al (2011) The secret \u201cspice\u201d: an undetectable toxic cause of seizure. Neurohospitalist 1(4):182\u2013186","journal-title":"Neurohospitalist"},{"issue":"14","key":"6205_CR18","doi-asserted-by":"publisher","first-page":"e1204","DOI":"10.1212\/WNL.0000000000005254","volume":"90","author":"O Devinsky","year":"2018","unstructured":"Devinsky O, Patel AD, Thiele EA et al (2018) Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome. Neurology 90(14):e1204\u2013e1211","journal-title":"Neurology"},{"issue":"1","key":"6205_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.bjp.0705726","volume":"142","author":"MA Diana","year":"2004","unstructured":"Diana MA, Marty A (2004) Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br J Pharmacol 142(1):9\u201319","journal-title":"Br J Pharmacol"},{"key":"6205_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fpsyt.2018.00055","volume":"9","author":"JS Elmore","year":"2018","unstructured":"Elmore JS, Baumann MH (2018) Repeated exposure to the \u201cSpice\u201d cannabinoid JWH-018 induces tolerance and enhances responsiveness to 5-HT1A receptor stimulation in male rats. Front Psychiatry 9:55","journal-title":"Front Psychiatry"},{"issue":"1","key":"6205_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lfs.2013.09.017","volume":"97","author":"WE Fantegrossi","year":"2014","unstructured":"Fantegrossi WE, Moran JH, Radominska-Pandya A et al (2014) Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to \u22069-THC: mechanism underlying greater toxicity? Life Sci 97(1):45\u201354","journal-title":"Life Sci"},{"key":"6205_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1475-925X-9-72","volume":"9","author":"FD Farf\u00e1n","year":"2010","unstructured":"Farf\u00e1n FD, Politti JC, Felice CJ (2010) Evaluation of EMG processing techniques using information theory. BioMed Eng OnLine 9:72","journal-title":"BioMed Eng OnLine"},{"key":"6205_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2017.10.007","volume":"338","author":"M Funada","year":"2018","unstructured":"Funada M, Takebayashi-Ohsawa M (2018) Synthetic cannabinoid AM 2201 induces seizures: involvement of cannabinoid CB1 receptors and glutamatergic transmission. Toxicol Appl Pharmacol 338:1\u20138","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"6205_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1124\/jpet.111.187757","volume":"340","author":"BC Ginsburg","year":"2012","unstructured":"Ginsburg BC, Schulze DR, Hruba L et al (2012) JWH-018 and JWH-073: \u22069-tetrahydrocannabinol-like discriminative stimulus effects in monkey. J Pharm Exp Ther 340(1):37\u201345","journal-title":"J Pharm Exp Ther"},{"key":"6205_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neuro.2015.08.007","volume":"50","author":"PH Gobira","year":"2015","unstructured":"Gobira PH, Vilela LR, Gon\u04abalves BD et al (2015) Cannabidiol, a cannabis sativa constituent, inhibits cocaine-induced seizures in mice: possible role of the mTOR pathway and reduction in glutamate release. Neurotoxicology 50:116\u2013121","journal-title":"Neurotoxicology"},{"key":"6205_CR26","doi-asserted-by":"publisher","first-page":"108374","DOI":"10.1016\/j.neuropharm.2020.108374","volume":"182","author":"DM Gomez","year":"2021","unstructured":"Gomez DM, Everett TJ, Hamilton LR et al (2021) Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212\u20132 and heroin in adult male rats. Neuropharmacology 182:108374","journal-title":"Neuropharmacology"},{"issue":"12","key":"6205_CR27","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.1172\/JCI130419","volume":"129","author":"B Gu","year":"2019","unstructured":"Gu B, Zhu M, Glass MR et al (2019) Cannabidiol attenuates seizures and EEG abnormalities in Angelman syndrome model mice. J Clin Invest 129(12):5462\u20135467","journal-title":"J Clin Invest"},{"issue":"6","key":"6205_CR28","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3109\/15563650.2014.925562","volume":"52","author":"H Gugelmann","year":"2014","unstructured":"Gugelmann H, Gerona R, Li C et al (2014) \u2018Crazy Monkey\u2019 poisons man and dog: human and canine seizures due to PB-22, a novel synthetic cannabinoid. Clin Toxicol 52(6):635\u2013638","journal-title":"Clin Toxicol"},{"issue":"9","key":"6205_CR29","doi-asserted-by":"publisher","first-page":"e0184352","DOI":"10.1371\/journal.pone.0184352","volume":"12","author":"B Hermans","year":"2017","unstructured":"Hermans B, Vink AS, Bennis FC et al (2017) The development and validation of an easy to use automatic QT-interval algorithm. PLoS ONE 12(9):e0184352","journal-title":"PLoS ONE"},{"issue":"8","key":"6205_CR30","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1111\/j.1476-5381.2012.02207.x","volume":"167","author":"AJ Hill","year":"2012","unstructured":"Hill AJ, Mercier MS, Hill TD et al (2012) Cannabidivarin is anticonvulsant in mouse and rat. Br J Pharmacol 167(8):1629\u20131642","journal-title":"Br J Pharmacol"},{"issue":"3","key":"6205_CR31","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/bph.12321","volume":"170","author":"TDM Hill","year":"2013","unstructured":"Hill TDM, Cascio MG, Romano B et al (2013) Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism. Br J Pharmacol 170(3):679\u2013692","journal-title":"Br J Pharmacol"},{"issue":"2","key":"6205_CR32","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/adb.12334","volume":"22","author":"AF Hoffman","year":"2017","unstructured":"Hoffman AF, Lycas MD, Kaczmarzyk JR et al (2017) Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid \u2018Spice\u2019 compounds: comparison with \u22069-tetrahydrocannabinol. Addict Biol 22(2):390\u2013399","journal-title":"Addict Biol"},{"issue":"2","key":"6205_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1124\/jpet.117.240572","volume":"362","author":"L Hruba","year":"2017","unstructured":"Hruba L, McMahon LR (2017) Apparent affinity estimates and reversal of the effects of synthetic cannabinoids AM-2201, CP-47,497, JWH-122, and JWH-250 by rimonabant in rhesus monkeys. J Pharm Exp Ther 362(2):278\u2013286","journal-title":"J Pharm Exp Ther"},{"key":"6205_CR34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuropharm.2019.01.002","volume":"148","author":"MN Huizenga","year":"2019","unstructured":"Huizenga MN, Sepulveda-Rodriguez A, Forcelli PA (2019) Preclinical safety and efficacy of cannabidivarin for early life seizures. Neuropharmacology 148:189\u2013198","journal-title":"Neuropharmacology"},{"key":"6205_CR35","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3389\/fphar.2018.01084","volume":"9","author":"RD Hutchison","year":"2018","unstructured":"Hutchison RD, Ford BM, Frank LN et al (2018) Atypical pharmacodynamic properties and metabolic profile of the abused synthetic cannabinoid AB-PINACA: potential contribution to pronounced adverse effects relative to \u22069-THC. Front Pharmacol 9:1084","journal-title":"Front Pharmacol"},{"issue":"1","key":"6205_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/jms.2026","volume":"47","author":"M Hutter","year":"2012","unstructured":"Hutter M, Broecker S, Kneisel S et al (2012) Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in \u2018herbal mixtures\u2019 using LC-MS\/MS techniques. J Mass Spectrom 47(1):54\u201365","journal-title":"J Mass Spectrom"},{"issue":"2","key":"6205_CR37","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1124\/jpet.109.159145","volume":"332","author":"NA Jones","year":"2010","unstructured":"Jones NA, Hill AJ, Smith I et al (2010) Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo. J Pharm Exp Ther 332(2):569\u2013577","journal-title":"J Pharm Exp Ther"},{"issue":"42","key":"6205_CR38","doi-asserted-by":"publisher","first-page":"11229","DOI":"10.1073\/pnas.1711351114","volume":"114","author":"JS Kaplan","year":"2017","unstructured":"Kaplan JS, Stella N, Catterall WA et al (2017) Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. Proc Natl Acad Sci USA 114(42):11229\u201311234","journal-title":"Proc Natl Acad Sci USA"},{"key":"6205_CR39","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3389\/fphar.2019.00595","volume":"10","author":"RC Kevin","year":"2019","unstructured":"Kevin RC, Anderson L, McGregor IS et al (2019) CUMYL-4CN-BINACA is an efficacious and potent pro-convulsant synthetic cannabinoid receptor agonist. Front Pharmacol 10:595","journal-title":"Front Pharmacol"},{"key":"6205_CR40","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nrcardio.2010.148","volume":"7","author":"A King","year":"2010","unstructured":"King A (2010) Neuropsychiatric adverse effects signal the end of the line for rimonabant. Nat Rev Cardiol 7:602","journal-title":"Nat Rev Cardiol"},{"issue":"50","key":"6205_CR41","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.3346\/jkms.2020.35.e427","volume":"35","author":"CM Koo","year":"2020","unstructured":"Koo CM, Kim SH, Lee JS et al (2020) Cannabidiol for treating Lennox-Gastaut syndrome and Dravet syndrome in Korea. J Korean Med Sci 35(50):e427","journal-title":"J Korean Med Sci"},{"key":"6205_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fnhum.2018.00121","volume":"12","author":"P Krauss","year":"2018","unstructured":"Krauss P, Schilling A, Bauer J et al (2018) Analysis of multichannel EEG patterns during human sleep: a novel approach. Front Hum Neurosci 12:121","journal-title":"Front Hum Neurosci"},{"issue":"8","key":"6205_CR43","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3109\/15563650.2011.609822","volume":"49","author":"J Lapoint","year":"2011","unstructured":"Lapoint J, James LP, Moran CL et al (2011) Severe toxicity following synthetic cannabinoid ingestion. Clin Toxicol (phila) 49(8):760\u2013764","journal-title":"Clin Toxicol (phila)"},{"key":"6205_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.eplepsyres.2019.03.015","volume":"154","author":"LC Laux","year":"2019","unstructured":"Laux LC, Bebin EM, Checketts D et al (2019) Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: expanded access program results. Epilepsy Res 154:13\u201320","journal-title":"Epilepsy Res"},{"issue":"8","key":"6205_CR45","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1021\/acschemneuro.7b00116","volume":"8","author":"M Longworth","year":"2017","unstructured":"Longworth M, Connor M, Banister SD et al (2017) Synthesis and pharmacological profiling of the metabolites of synthetic cannabinoid drugs APICA, STS-135, ADB-PINACA, and 5F-ADB-PINACA. ACS Chem Neurosci 8(8):1673\u20131680","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"6205_CR46","doi-asserted-by":"publisher","first-page":"e85689","DOI":"10.1371\/journal.pone.0085689","volume":"9","author":"RL Lux","year":"2014","unstructured":"Lux RL, Sower CT, Allen N et al (2014) The application of root mean square electrocardiography (RMS ECG) for the detection of acquired and congenital long QT syndrome. PLoS ONE 9(1):e85689","journal-title":"PLoS ONE"},{"issue":"5","key":"6205_CR47","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.physbeh.2009.09.005","volume":"98","author":"A L\u03cbttjohann","year":"2009","unstructured":"L\u03cbttjohann A, Fabene PF, van Luijtelaar G (2009) A revised Racine\u2019s scale for PTZ-induced seizures in rats. Physiol Behav 98(5):579\u2013586","journal-title":"Physiol Behav"},{"issue":"1","key":"6205_CR48","doi-asserted-by":"publisher","first-page":"10516","DOI":"10.1038\/s41598-017-10447-2","volume":"7","author":"O Malyshevskaya","year":"2017","unstructured":"Malyshevskaya O, Aritake K, Kaushik MK et al (2017) Natural (\u22069-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB1 receptor. Sci Rep 7(1):10516","journal-title":"Sci Rep"},{"issue":"3\u20134","key":"6205_CR49","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/00207459308986666","volume":"73","author":"K Mann","year":"1993","unstructured":"Mann K, B\u00e4cker P, R\u00f6schke J (1993) Dynamical properties of the sleep EEG in different frequency bands. Int J Neurosci 73(3\u20134):161\u2013169","journal-title":"Int J Neurosci"},{"issue":"12","key":"6205_CR50","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","volume":"11","author":"G Marsicano","year":"1999","unstructured":"Marsicano G, Lutz B (1999) Expression of the cannabinoid receptor CB1 in distinct neural subpopulations in the adult mouse forebrain. Eur J Neurosci 11(12):4213\u20134225","journal-title":"Eur J Neurosci"},{"issue":"1","key":"6205_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0013-4694(78)90336-X","volume":"45","author":"M Matsuzaki","year":"1978","unstructured":"Matsuzaki M (1978) Alteration in pattern of EEG activities and convulsant effect of cocaine following chronic administration in the rhesus monkey. Electroencephalogr Clin Neurophysiol 45(1):1\u201315","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"1","key":"6205_CR52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1523\/JNEUROSCI.4503-03.2004","volume":"24","author":"M Melis","year":"2004","unstructured":"Melis M, Pistis M, Perra S et al (2004) Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 24(1):53\u201362","journal-title":"J Neurosci"},{"issue":"2","key":"6205_CR53","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.neuron.2014.06.030","volume":"83","author":"AV Naydenov","year":"2014","unstructured":"Naydenov AV, Horne EA, Cheah CS et al (2014) ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6\/2 mice. Neuron 83(2):361\u2013371","journal-title":"Neuron"},{"issue":"11","key":"6205_CR54","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3390\/pharmaceutics12111036","volume":"12","author":"EJ Park","year":"2020","unstructured":"Park EJ, Park R, Jeon JH et al (2020) Inhibitory effect of AB-PINACA, indazole carboxamide synthetic cannabinoid, on human major drug-metabolizing enzymes and transporters. Pharmaceutics 12(11):1036","journal-title":"Pharmaceutics"},{"key":"6205_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.eplepsyres.2015.09.008","volume":"117","author":"KD Phelan","year":"2015","unstructured":"Phelan KD, Shwe UT, William DK et al (2015) Pilocarpine-induced status epilepticus mice: a comparison of spectral analysis of electroencephalogram and behavioral grading using the Racine scale. Epilepsy Res 117:90\u201396","journal-title":"Epilepsy Res"},{"issue":"2","key":"6205_CR56","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/epi.13648","volume":"58","author":"KD Phelan","year":"2017","unstructured":"Phelan KD, Shwe UT, Cozart MA et al (2017) TRPC3 channels play a critical role in the theta component of pilocarpine-induced status epilepticus in mice. Epilepsia 58(2):247\u2013254","journal-title":"Epilepsia"},{"issue":"2","key":"6205_CR57","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.taap.2013.03.012","volume":"269","author":"M Rajasekaran","year":"2013","unstructured":"Rajasekaran M, Brents LK, Franks LN et al (2013) Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. Toxicol Appl Pharmacol 269(2):100\u2013108","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"6205_CR58","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2337\/db11-0477","volume":"61","author":"M Rajesh","year":"2012","unstructured":"Rajesh M, B\u00e1tkai S, Kechrid M et al (2012) Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. Diabetes 61(3):716\u2013727","journal-title":"Diabetes"},{"issue":"49","key":"6205_CR59","doi-asserted-by":"publisher","first-page":"11070","DOI":"10.1523\/JNEUROSCI.3695-04.2004","volume":"24","author":"AC Riegel","year":"2004","unstructured":"Riegel AC, Lupica CR (2004) Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J Neurosci 24(49):11070\u201311078","journal-title":"J Neurosci"},{"key":"6205_CR60","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0165-3806(02)00306-1","volume":"136","author":"E Romero","year":"2002","unstructured":"Romero E, Fern\u00e1ndez B, Sagredo O, Gomez N, Urig\u00fcen L, Guaza C et al (2002) Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats. Brain Res Dev Brain Res 136:85\u201392","journal-title":"Brain Res Dev Brain Res"},{"issue":"1","key":"6205_CR61","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s13181-011-0182-2","volume":"8","author":"AB Schneir","year":"2012","unstructured":"Schneir AB, Baumbacher T (2012) Convulsions associated with the use of a synthetic cannabinoid product. J Med Toxicol 8(1):62\u201364","journal-title":"J Med Toxicol"},{"issue":"5","key":"6205_CR62","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jemermed.2014.12.038","volume":"48","author":"MD Schwartz","year":"2015","unstructured":"Schwartz MD, Trecki J, Edison LA et al (2015) A common source outbreak of severe delirium associated with exposure to the novel synthetic cannabinoid ADB-PINACA. J Emerg Med 48(5):573\u2013580","journal-title":"J Emerg Med"},{"key":"6205_CR63","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1749-6632.1996.tb17454.x","volume":"801","author":"K Shimosato","year":"1996","unstructured":"Shimosato K, Watanabe S, Marley RJ et al (1996) One-way cross-sensitization and cross-tolerance to seizure activity from cocaine to lidocaine. Ann NY Acad Sci 801:340\u2013352","journal-title":"Ann NY Acad Sci"},{"issue":"4","key":"6205_CR64","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/08998280.2015.11929313","volume":"28","author":"W Srisung","year":"2015","unstructured":"Srisung W, Jamal F, Prabhakar S (2015) Synthetic cannabinoids and acute kidney injury. Proc (baylor Univ Med Cent) 28(4):475\u2013477","journal-title":"Proc (baylor Univ Med Cent)"},{"issue":"1","key":"6205_CR65","doi-asserted-by":"publisher","first-page":"G110","DOI":"10.1152\/ajpgi.00148.2003","volume":"286","author":"M Storr","year":"2004","unstructured":"Storr M, Sibaev A, Marsicano G et al (2004) Cannabinoid 1 receptor type-1 modulates excitatory and inhibitory neurotransmission in mouse colon. AM J Physiol Gastrointest Liver Physiol 286(1):G110\u2013G117","journal-title":"AM J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"6205_CR66","first-page":"2442","volume":"40","author":"AJ Straiker","year":"1999","unstructured":"Straiker AJ, Maguire G, Mackie K et al (1999) Localization of cannabinoid CB1 receptors in the human anterior eye and retina. Invest Ophthalmol vis Sci 40(10):2442\u20132448","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"1","key":"6205_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","volume":"54","author":"RJ Tait","year":"2016","unstructured":"Tait RJ, Caldicott D, Mountain D et al (2016) A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol 54(1):1\u201313","journal-title":"Clin Toxicol"},{"issue":"6","key":"6205_CR68","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.ajem.2018.08.048","volume":"37","author":"M Tatusov","year":"2019","unstructured":"Tatusov M, Mazer-Amirshahi M, Abbasi A et al (2019) Clinical effects of reported synthetic cannabinoid exposure in patients admitted to the intensive care unit. Am J Emerg Med 37(6):1060\u20131064","journal-title":"Am J Emerg Med"},{"key":"6205_CR69","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0014-2999(01)01267-5","volume":"430","author":"A Tseng","year":"2001","unstructured":"Tseng A, Craft R (2001) Sex differences in antinociceptive and motoric effects of cannabinoids. Eur J Pharmacol 430:41\u201347","journal-title":"Eur J Pharmacol"},{"key":"6205_CR70","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yebeh.2019.02.029","volume":"95","author":"J Van Erum","year":"2019","unstructured":"Van Erum J, Van Dam D, Deyn De, pp. (2019) PTZ-induced seizures in mice require a revised Racine scale. Epilepsy Behav: E&B. 95:51\u201355","journal-title":"Epilepsy Behav: E&B."},{"key":"6205_CR71","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.yebeh.2017.07.014","volume":"75","author":"LR Vilela","year":"2017","unstructured":"Vilela LR, Lima IV, Kunsch EB et al (2017) Anticonvulsant effects of cannabidiol in the pentylenetetrazol model: pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels. Epilepsy Beh: e&b 75:29\u201335","journal-title":"Epilepsy Beh: e&b"},{"key":"6205_CR72","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1124\/jpet.115.227181","volume":"356","author":"PF Weed","year":"2016","unstructured":"Weed PF, Filipeanu CM, Ketchum MJ, Winsauer PJ (2016) Chronic \u03949-tetrahydrocannabinol during adolescence differentially modulates striatal CB1 receptor expression and the acute and chronic effects on learning in adult rats. J Pharmacol Exp Ther 356:20\u201331","journal-title":"J Pharmacol Exp Ther"},{"key":"6205_CR73","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.11.035","volume":"172","author":"JL Wiley","year":"2017","unstructured":"Wiley JL, Lefever TW, Marusich JA, Craft RM (2017) Comparison of the discriminative stimulus and response rate effects of \u03949-tetrahydrocannabinol and synthetic cannabinoids in female and male rats. Drug Alcohol Depend 172:51\u201359","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"6205_CR74","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1124\/jpet.118.251157","volume":"368","author":"CD Wilson","year":"2019","unstructured":"Wilson CD, Tai S, Ewing L et al (2019) Convulsant effects of abused synthetic cannabinoids JWH-018 and 5F-AB-PINACA are mediated by agonist actions at CB1 receptors in mice. J Pharm Exp Ther 368(2):146\u2013156","journal-title":"J Pharm Exp Ther"},{"issue":"3","key":"6205_CR75","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1208\/s12248-015-9721-0","volume":"17","author":"A Wohlfarth","year":"2015","unstructured":"Wohlfarth A, Castaneto MS, Zhu M et al (2015) Pentylindole\/pentylindazole synthetic cannabinoids and their 5-fluoro analogs produce different primary metabolites: metabolite profiling for AB-PINACA and 5F-AB-PINACA. AAPS J 17(3):660\u2013677","journal-title":"AAPS J"},{"key":"6205_CR76","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neuro.2019.04.003","volume":"73","author":"CE Wolfe","year":"2019","unstructured":"Wolfe CE, Wood DM, Dines A et al (2019) Seizures as a complication of recreational drug use: analysis of the Euro-DEN Plus data-set. Neurotoxicology 73:183\u2013187","journal-title":"Neurotoxicology"},{"issue":"4","key":"6205_CR77","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s13181-016-0558-4","volume":"12","author":"M Zaurova","year":"2016","unstructured":"Zaurova M, Hoffman RS, Vlahov D et al (2016) Clinical effects of synthetic cannabinoid receptor agonists compared with marijuana in emergency department patients with acute drug overdose. J Med Toxicol 12(4):335\u2013340","journal-title":"J Med Toxicol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06205-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-022-06205-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06205-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T00:03:42Z","timestamp":1666483422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-022-06205-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,6]]},"references-count":77,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["6205"],"URL":"https:\/\/doi.org\/10.1007\/s00213-022-06205-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,6]]},"assertion":[{"value":"5 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}